Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine Dose-finding in Chronic Idiopathic Urticaria
NCT00199238Phase 2Terminated
- Sponsor
- Uriach
- Start
- Oct 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rupatadine in chronic idiopathic urticaria (CIU), sponsored by Uriach. Started Oct 2002; status: terminated.
02
Drugs
rupatadine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT00199238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199238.